Stay updated on Milademetan Safety in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page
- Check3 days agoChange DetectedThe page adds user guidance sections and a reworded Intervention/Treatment heading, and displays the recruitment status 'No longer looking for participants' while updating the revision from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check10 days agoChange DetectedA new page revision tag v3.5.5 was added, replacing the previous v3.5.4, indicating a small backend update to the page without user-visible content changes.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision line now displays Revision: v3.5.4, and the prior Revision: v3.5.3 entry was removed, reflecting a minor update to the page's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page’s revision identifier has been updated to v3.5.3, replacing the previous v3.5.2. This reflects a platform update without changes to the shown study details.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Acute myeloid leukemia as a listed condition/keyword on the study page.SummaryDifference0.0%

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.